@misc{indiciaebb15ac4ffcbe,
  title = {Drug development of an affinity enhanced, broadly neutralizing heavy chain only antibody that restricts SARS-CoV-2 in hamsters},
  author = {Schepens, B. and van Schie, L. and Nerinckx, W. and Roose, K. and Van Breedam, W. and Fijalkowska, D. and Devos, S. and Weyts, W. and De Cae, S. and Vanmarcke, S. and Lonigro, C. and Eeckhaut, H. and Van Herpe, D. and Borloo, J. and Oliveira, A. F. and Catani, J. P. and Creytens, S. and De Vlieger, D. and Michielsen, G. and Marchan, J. C. Z. and Moschonas, G. D. and Rossey, I. and Sedeyn, K. and Van Hecke, A. and Zhang, X. and Langendries, L. and Jacobs, S. and ter Horst, S. and Seldeslachts, L. and Liesenborghs, L. and Boudewijns, R. and Tibaut, H. J. and Dallmeier, K. and Vande Velde, G. and Weynand, B. and Beer, J. and Schnepf, D. and Ohnemus, A. and Foo, C. S.-Y. and Abdelnabi, R. and Maes, P. and Kaptein, S.},
  year = {2021},
  doi = {10.1101/2021.03.08.433449},
  url = {https://www.biorxiv.org/content/10.1101/2021.03.08.433449v1},
  note = {Source identifier: 10.1101/2021.03.08.433449}
}